Strs Ohio Grows Stock Holdings in HealthEquity, Inc. $HQY

Strs Ohio lifted its stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 84.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 64,400 shares of the company’s stock after purchasing an additional 29,400 shares during the quarter. Strs Ohio owned about 0.08% of HealthEquity worth $5,900,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of HQY. AQR Capital Management LLC raised its position in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after purchasing an additional 661,795 shares during the last quarter. Westfield Capital Management Co. LP raised its position in shares of HealthEquity by 35.7% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock valued at $162,688,000 after purchasing an additional 451,450 shares during the last quarter. Woodline Partners LP purchased a new position in shares of HealthEquity in the 3rd quarter valued at approximately $26,193,000. Vanguard Group Inc. raised its position in shares of HealthEquity by 2.9% in the 3rd quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock valued at $828,883,000 after purchasing an additional 243,549 shares during the last quarter. Finally, Marshall Wace LLP raised its position in shares of HealthEquity by 460.2% in the 3rd quarter. Marshall Wace LLP now owns 293,182 shares of the company’s stock valued at $27,785,000 after purchasing an additional 240,847 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. The Goldman Sachs Group lowered shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective for the company. in a research report on Friday, January 9th. BTIG Research decreased their price objective on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Barrington Research decreased their price objective on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating for the company in a research report on Wednesday, March 18th. Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. Finally, BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $85.00 to $105.00 in a research report on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $111.79.

Check Out Our Latest Stock Report on HealthEquity

HealthEquity Stock Performance

HQY opened at $82.18 on Tuesday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $6.94 billion, a PE ratio of 33.41, a P/E/G ratio of 1.50 and a beta of 0.19. The firm has a 50 day moving average of $80.91 and a two-hundred day moving average of $87.96.

HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The company had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. The firm’s quarterly revenue was up 7.3% compared to the same quarter last year. On average, analysts anticipate that HealthEquity, Inc. will post 3.84 EPS for the current year.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Recommended Stories

• Five stocks we like better than HealthEquity

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).